Clinical Applications of Granulocyte Colony Stimulating Factor (G-CSF)

References

• Bonilla M. A., and the Severe Neutropenia Study Group in conjunction with Amgen Inc., Thousand Oaks, CA. Clinical efficacy of recombinant human granulocyte colony stimulating factor (r‐metHuG‐CSF) in patients with severe chronic neutropenia. Blood 1990; 76(Suppl 1)523, (Abstract)
   PubMedGoogle Scholar
• Bonilla M. A., Gillio A. P., Ruggeiro M., Kernan N. A., Brochstein J. A., Abboud M., Fumagalli L., Vincent M., Gabrilove J. L., Welte K., Souza L. M., O'Reilly L. M. Effects of recombinant human granulocyte colony‐stimulating factor on neutropenia in patients with congenital agranulocytosis. N. Engl. J. Med. 1989; 320: 1574–1580
   PubMed Web of Science ®Google Scholar
• Bronchud M. H., Howell A., Crowther D., Hopwood P., Souza L., Dexter T. M. The use of granulocyte colony stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br. J. Cancer 1989; 60: 121–125
   PubMed Web of Science ®Google Scholar
• Bronchud M. H., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br. J. Cancer 1987; 56: 809–813
   PubMed Web of Science ®Google Scholar
• Crawford J., Ozer H., Johnson D., and the G‐CSF Study Group. Granulocyte colony stimulating factor: prevention of chemotherapy induced febrile neutropenia (FN) in patients with small cell lung cancer (SCLC). ASCO 1990; 9: 884, (Abstract)
   Google Scholar
• Gabrilove J. L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M. A. S., Clarkson B., Oettgen H., Alton K., Welte K., Souza L. Granulocyte colony stimulating factor reduces the neutropenia and associated morbidity of chemotherapy for transitional cell carcinoma of the urothelium. N. Engl. J. Med. 1988; 318: 1414–1422
   PubMed Web of Science ®Google Scholar
• Gillio A. P., Bonilla M. A., Potter G. K., Gabrilove J. L., O'Reilly R. J., Souza L. M., Welte K. Effects of recombinant human granulocyte‐colony stimulating factor on hematopoietic reconstitution following autologous bone marrow transplantation in primates transplant. Proc XIX 1988; 7(Suppl 1)153.30
   Google Scholar
• Glaspy J. A., Baldwin G. C., Robertson P. A., Souza L., Vincent M., Ambersley J., Golde D. W. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony‐stimulating factor. Annals of Internal Medicine 1988; 109: 789–795
   PubMed Web of Science ®Google Scholar
• Hammond W. P., Price T. H., Souza L. M., Dale D. C. Treatment of cyclic neutropenia with granulocyte colony stimulating factor. N. Engl. J. Med. 1989; 320: 1306–1311
   PubMed Web of Science ®Google Scholar
• Jakubowski A., Andreeff M., Tafuri A., Shieh J. H., Sheridan C., Gordon M., Sinha S., Homge M., Vincent M., Alton K., Moore M. A. S., Gabrilove J. L. In vivo and in vitro studies of rhG‐CSF in acute nonlymphocytic leukemia. Blood 1989a; 74(Suppl 1)1034, (Abstract)
   Google Scholar
• Jakubowski A., Souza L., Kelly F., Fain K., Budman D., Clarkson B., Bonilla M. A., Moore M. A. S., Gabrilove J. Effects of human granulocyte colony stimulating factor in a patient with idiopathic neutropenia. N. Engl. J. Med. 1989b; 320: 38–42
   PubMed Web of Science ®Google Scholar
• Kojima S., Fukuda M., Miyajima Y., Matsuyama T., Horibe K. Treatment of aplastic anemia in children with recombinant human granulocyte colony‐stimulating factor. Blood 1991; 77: 937–941
   PubMed Web of Science ®Google Scholar
• Lothrop C. D., Jones J. B., Warren D. J., Moore M. A. S., Souza L. M. Correction of cyclic hematopoiesis with recombinant human granulocyte colony stimulating factor. Blood 1988; 72: 1324–1328
   PubMed Web of Science ®Google Scholar
• Miles S. A., Mitsuyasu R. T., Lee K., Moreno J., Alton K., Egrie J. C., Souza L., Glaspy J. A. Recombinant human granulocyte colony stimulating factor increases circulating burst forming unit erythron and red blood cell production in patients with severe human immunodeficiency virus infection. Blood 1990; 75: 137–2142
   Google Scholar
• Moore M. A. S., Stolfi R. L., Martin D. S. Hematologic effects of interleukin‐1 beta, granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in tumor bearing mice treated with Fluorouracil. J. Natl. Cancer Inst. 1990; 82: 1031–1037
   PubMed Web of Science ®Google Scholar
• Moore M. A. S., Warren D. J. Synergy of interleukin‐1 and granulocyte colony‐stimulating factor: in vivo stimulation of stem‐cell recovery and hematopoietic regeneration following 5‐fluorouracil treatment in mice. Proc. Natl. Acad. Sci. 1987; 84: 7134–7138
   PubMed Web of Science ®Google Scholar
• Morstyn G., Campbell L., Lieschke G., Layton J., Maher D., O'Connor M., Green M., Sheridan W., Vincent M., Alton K., Souza L. M., McGrath K., Fox R. M. Treatment of chemotherapy‐induced neutropenia by subcutaneously administered granulocyte colony stimulating factor with optimization of dose and duration of therapy. J. Clin. Oncol. 1989; 7: 1554–1562
   PubMed Web of Science ®Google Scholar
• Morstyn G., Souza L. M., Keech J., Sheridan W., Campbell L., Alton N. K., Green M., Metcalf D. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. 1988; 1: 667–671
   Google Scholar
• Nagler A., Binet C., Mackichan M. L., Negrin R., Bangs C., Donlon T., Greenberg P. Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony‐stimulating factor (CSF) and granulocyte‐monocyte CSF. Blood 1990; 76: 1299–1307
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Haeuber D. H., Nagler A., Olds L. C., Donlon T., Souza L. M., Greenberg P. L. Treatment of myelodysplastic syndromes with recombinant granulocyte colony stimulating factor. Annals, of Int. Med. 1989; 110: 976–981
   PubMed Web of Science ®Google Scholar
• Neidhart J., Mangalik A., Kohler W., Stidley C., Saiki J., Duncan P., Souza L., Downing M. Granulocyte colony‐stimulating factor stimulates recovery of granulocytes in patients receiving dose‐intensive chemotherapy without bone marrow transplantation. J. Clin. One. 1989; 7: 1685–1692
   PubMed Web of Science ®Google Scholar
• Ono M., Matsumoto M., Matsubara S., Tomioka S., Asano S. Protective effect of human granulocyte colony‐stimulating factor on bacterial and fungal infections in neutropenic mice. Behring Inst. Mitt. 1988; 83: 216–221
   PubMedGoogle Scholar
• Ohno R., Tomonaga M., Kobayashi T., Kanamaru A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A. B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effect of granulocyte colony‐stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N. Engl. J. Med. 1990; 323: 871–877
   PubMed Web of Science ®Google Scholar
• Peters W. P., Kurtzberg J., Atwater S., Borowitz M., Gilbert C., Rao M., Currie M., Shogan J., Jones R. B., Shpall E. J., Souza L. Comparative effects of rHuG‐CSF and rHuGM‐CSF on hematopoietic reconstirution and granulocyte function following high dose chemotherapy and autologous bone marrow transplantation (ABMT). Blood 1988; 72: 432, (Abstract)
   Google Scholar
• Sheridan W. P., Wolf M., Lusk J., Layton J. E., Souza L. M., Morstyn G., Dodds A., Maher D., Green M. D., Fox R. M. Granulocyte colony stimulating factor and neutrophil recovery after high dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891–894
   PubMed Web of Science ®Google Scholar
• Souza L. M., Boone T. C., Gabrilove G., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewski J., Lu H., Chen K. K., Platzer E., Moore M. A. S., Mertelsmann R., Welte K. Recombinant pluripotent human granulocyte colony‐stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
   PubMed Web of Science ®Google Scholar
• Taylor K. M., Jagannath S., Spitzer G., Spinolo J. A., Tucker S. L., Fogel B., Cabanillas F. F., Hagemeister F. B., Souza L. M. Recombinant human granulocyte colony‐stimulating factor hastens granulocyte recovery after high‐dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J. Clin. Oncol. 1989; 7: 1791–1799
   PubMed Web of Science ®Google Scholar
• Welte K., Bonilla M. A., Gillio A. P., Boone T. C., Potter G. K., Gabrilove J. L., Moore M. A. S., O'Reilly R. J., Souza L. M. Recombinant human G‐CSF: effects on hematopoiesis in normal and cyclophosphamide treated primates. J. Exp. Med. 1987a; 165: 941–948
   PubMed Web of Science ®Google Scholar
• Welte K., Bonilla M. A., Gillio A. P., O'Reilly R. J., Gabrilove J., Potter G. K., Boone T., Souza L. In vivo effects of recombinant human G‐CSF in therapy induced neutropenias in primates. Exp. Hematol. 1987; 15: 72, (Abstract)
   PubMedGoogle Scholar
• Welte K., Platzer E., Lu L., Gabrilove J., Mertelsmann R., Moore M. A. S. Purification and biological characterization of human pluripotent hematopoietic colony stimulating factor. Proc. Natl. Acad. Sci. 1985; 82: 1526–1530
   PubMed Web of Science ®Google Scholar